Hill-Rom EPS rockets 88 percent as profits almost double
Hill-Rom Holdings Inc. (NYSE:HRC) reported profits of $50.7 million, or 79 cents per diluted share, on revenue of $396.6 million during the three months ended Sept. 30. That compares with profits of $26.4 million, or 42 cents per diluted share, on revenue of $363.3 million during the same period last year.
Read more
Bruker profits jump 67 percent on strong sales growth
Bruker Corp. (NSDQ:BRKR) reported profits of $27.4 million, or 17 cents per diluted share, on revenue of $310.2 million during the three months ended Sept. 30. That compares with profits of $16.4 million, or 10 cents per diluted share, on revenue of $265.1 million during the same period last year.
Read more
Affymetrix puts a little black ink in its books
Affymetrix Inc. (NSDQ:AFFX) posted net income of approximately $968,000, or 1 cent per diluted share, on sales of $67.3 million during the three months ended Sept. 30. That compares with a net loss of $8.8 million, or 13 cents per diluted share, on sales of $66.2 million during the same period last year.
Read more
Omnicell profits rise after modest revenue increase
Omnicell Inc. (NSDQ:OMCL) posted net income of $1.3 million, or 4 cents per diluted share, on sales of $56.3 million during the three months ended Sept. 30 That compares with net income of approximately $854,000, or 3 cents per diluted share, on sales of $54.0 million during the same period last year.
Read more
Stericycle profits get a 23 percent bump
Stericycle Inc. (NSDQ:SRCL) reported profits of $57.3 million, or 65 cents per diluted share, on sales of $363.0 million during the three months ended Sept. 30. That compares with profits of $46.6 million, or 54 cents per diluted share, on sales of $297.8 million during the same period last year.
Read more
Caliper revenues drop slightly, but losses ease
Caliper Life Sciences Inc. (NSDQ:CALP) recorded a loss of $1.3 million, or 3 cents per diluted share, on revenue of $29.7 million during the three months ended Sept. 30. That compares with a loss of $3.4 million, or 7 cents per diluted share, on sales of $32.2 million during the same period last year.
Read more
Encision breaks out the red ink as sales drop 11 percent
Encision Inc. (Pink Sheets:ECIA) recorded a loss of $145 thousand, or 2 cents per diluted share, on revenue of $2.9 million during the three months ended Sept. 30. That compares with profits of approximately $46,000, or 1 cent per diluted share, on revenue of $3.2 million during the same period last year.
Read more
Orthofix net income up 38 percent
Orthofix International N.V. (NSDQ:OFIX) reported profits of $8.5 million, or 48 cents per diluted share, on sales of $138.9 million during the three months ended Sept. 30. That compares with profits of $6.2 million, or 36 cents per diluted share, on sales of $135.1 million during the same period last year.
Read more
Endologix logs a 30 percent sales bump, but remains in the red
Endologix Inc. (NSDQ:ELGX) recorded a loss of approximately 466,000, or 1 cent per diluted share, on sales of $17.9 million during the three months ended Sept. 30. That compares with a loss of approximately $156,000, with a negligeable loss per diluted share, on sales of $13.8 million during the same period last year.
Read more
Palomar sales rise, but losses jump almost six fold on increased expenses
Palomar Medical Technologies Inc. (NSDQ:PMTI) recorded a loss of approximately $2.0 million, or 11 cents per diluted share, on revenues of $15.8 million during the three months ended Sept. 30. That compares with a loss of $296,587, or 2 cents per diluted share, on revenues of $14.5 million during the same period last year.
Read more
Uroplasty revenues edge up, but so do losses as expenses increase across the board
Uroplasty Inc. (NSDQ:UPI) recorded a loss of approximately $922,672, or 5 cents per diluted share, on sales of $3.2 million during the three months ended Sept. 30. That compares with a loss of $874,659, or 6 cents per diluted share, on revenues of $3.0 million during the same period last year.
Read more
Hanger Orthopedic sales rise, but on relocation costs hit profits
Hanger Orthopedic Group Inc. (NYSE:HGR) reported profits of $6.9 million, or 21 cents per diluted share, on sales of $206.7 million during the three months ended Sept. 30. That compares with profits of $9.6 million, or 31 cents per diluted share, on sales of $192.3 million during the same period last year.
Read more